Lynn Institute of Denver
5250 Leetsdale Dr., Suite 208
Denver, CO 80246
Study Information (303) 377-5966
Main (303) 371-9432
Corporate (405) 602-3927
Fax (303) 371-9521
After Hours 1 (866) 863-6114
The Lynn Institute of Denver opened in 2010 and represents Lynn Health Science Institute’s most recent expansion site. Located in Glendale, in the heart of Denver, the site offers easy access to patients. The site is open Monday – Friday.
The site generally recruits for a variety of studies, such as: Diabetes, IBS, Contraception, Pain Studies, Obesity, Pulmonary Diseases, Arthritis and Flu Treatments.
Principal Investigator: Dr. Odekirk
Manager/Study Coordinator: Kelly Radin, CCRC
Kelly has worked in clinical trials since 1993 and she has been with the Lynn Institute since 2005.
Study Coordinator: Christina Gallegos, MA
Christina has worked in clinical trials since 1991 and she has been with the Lynn Institute since 2012.
For more information or to participate in a clinical trial contact us at (303) 371-9432 or fill out our participant information form.
We are currently seeking participants with the following medical conditions:
We are currently seeking patients at least 12 years of age, diagnosed with persistent asthma, and frequently need to use an inhaler. Qualified participants may be compensated for time and travel.
Cardiovascular Risk and High Cholesterol
Do you have a history of heart disease or are at high risk? We are currently seeking patients for two studies who are at high risk for cardiovascular disease and taking a statin or other lipid lowering treatment. Qualified participants may be compensated. Find out more about this study.
Dyslipidemia w/ CV Risks
Lynn Institute is currently seeking patients 18 -80 years of age who may have the flu with two of the following symptoms: cough, sore throat, headache, nasal congestion, body aches and pains, or fatigue. Symptoms must have begun less than 48 hours earlier. Qualified participants may be compensated for time and travel.
We are currently seeking patients on a stable diet and statin therapy that are also at high risk for a future cardiovascular event. Qualified participants may receive compensation for time and travel. View the ad.
Type II Diabetes
Over eighteen million Americans suffer from Diabetes. Lynn Institute is currently conducting multiple research studies of investigational medications for Type 2 Diabetes.
1. African Americans aged 18 years or older diagnosed with Type 2 Diabetes. Eligible participants will receive study-related medical care and investigational medicine at no cost. Reimbursement may be available for certain study related travel expenses.
2. If you have been diagnosed with Type 2 Diabetes, you may be eligible to participate in a clinical research study of an investigational oral diabetes medication. You may qualify for the study if you have Type 2 Diabetes, AND you are age 30 or older and have had a heart attack, stroke, or other heart or vascular problem. If you qualify, you will receive study-related examinations and study medication at no cost.
3. Do you take Crestor, Lipitor, Zocor or the generic equivalent? Do you have Type 2 Diabetes or have had a stroke or heart attack? If you answered yes, and are age 18 or older you may qualify to participate in a clinical research study at the Lynn Institute. Qualified participants will receive investigational medication, study-related examinations and compensation for time and travel.
Obesity w/CV outcomes
Please call Christina for more information.